Actovegin - kahi lāʻau lapaʻau e kōkua i ka hoʻomau ʻana i nā kaʻina metabolic i loko o nā kīʻaha a me nā kīʻaha koko, hoʻoulu i ke kaʻina hana hoʻoponopono.
Inoa Kūʻai ʻole honua
ʻAʻole.
ʻO ka inoa kalepa ʻo Actovegin®. I Latin - Actovegin.
ʻO nā ampou me kahi wai pōpoki a i ʻole e hoʻoneʻe paha i kahi maʻi maʻi.
ATX
B06AB (Nā huahana koko ʻē aʻe)
E hoʻokuʻu i nā palapala a me ka ʻano
ʻO nā ampou me kahi wai pōpoki a i ʻole e hoʻoneʻe paha i kahi maʻi maʻi.
ʻO ka papa kaiola: ditu hemoderivative, 40 mg / ml.
Hoʻopuka ʻia e ka dialysis, membrane ka hoʻokaʻawale a me ka hoʻokaʻawale i nā hapa koko o nā holoholona ʻōpiopio, hānai i ka waiū kūʻokoʻa.
Mea hoʻohui ʻokoʻa: wai no ka injection.
Hiki ke hana ia e nā ʻoihana lapaʻau ʻo Takeda Austria GmbH (Austria) a i ʻole Takeda Pharmaceuticals LLC (RF). Hoʻopili ʻia ma 2 ml, 5 a 10 ml paha i ka nui o ka ʻāpana piha o 5 mau pcs. i ka contoured pale pale i hana ʻia me ka palaka. Nā pēpē 1, 2 a i ʻole 5 mau kelepona i nā pahu pepa.
Aia ka lāʻau i ka pūʻulu o nā antihypoxants.
Ma kēlā me kēia kāpana o ke kāleka pono e hoʻopū ʻia kahi mea hoʻopuni lapalapa me kahi palapala holographic a me ke kaohi o ka wehe mua.
Ka hana lāʻau lapaʻau
No nā lālā o nā antihypoxants. Ma ka manawa like he 3 mau ʻano o nā hopena:
- nā neuroprotective (pale i ka make o nā pūpū o nā lolo - nā neurons - ma muli o nā hopena maikaʻi ʻole o nā hana kūloko a i ʻole nā hopena waho;
- hiki i ka metabolic (hoʻolaha i ka hoʻopili ʻana o ka adenosine triphosphate (ATP) a hoʻonui i ka ikehu o nā pūpuna);
- microcirculatory (ʻoi aku ka maikaʻi o ka hoʻoliʻiliʻi ʻana o nā ʻōlaola ma nā ʻāpana a me nā kīʻaha o ke kino).
Kōkua i ka hoʻomaikaʻi ʻana i ka sorption a me ka hoʻoulu ʻana o ka oxygen a me ka glucose.
Hoʻopau kēia i ka hoʻokumu ʻana o nā hana apoptotic i hoʻonāukiuki ʻia e beta-amyloid (Aβ25-35). Ke hoʻololi nei i ka kahe o ke kaila nappa kappa B (NF-kB), he mea hoʻoikaika nui i ka wā o nā kaʻina hana i ke kikowaena waena a me ka pono o nā pelaleka a me ka apoptosis.
Loaʻa ia i kona hopena maikaʻi ma ka microcirculation a me ke kahe koko i loko o nā capillaries, e hoʻemi ana i ka pae pericapillary a me ka pehu diastolic. Ua hōʻike ʻia nō ka nānā ʻia ana o ka hopena o ka lāʻau ma hope o 30 mau minuke, a ʻo ka hopena kiʻekiʻe loa he 3 mau hola ma hope o ka hoʻokō ʻana.
Loaʻa ka Actovegin i kahi hopena maikaʻi ma ka microcirculation a me ke kahe koko i nā capillaries.
Lapaʻau lāʻau
ʻO ka loaʻa ʻana o ka lāʻau i nā mea physiological i loaʻa i loko o ke kino, ʻo kāna mau pharmacokinetic e like me nā ʻōnaehana laboratory hiki ʻole i hoʻopaʻa ʻia.
Mea i kuhikuhi ʻia
Hoʻololi ʻia ka Actovegin 40 i nā regimens lapaʻau ʻoihana.
- nā maʻi kūlike o nā ʻano etiologies;
- pehu a me nā pōpoki cerebrovascular;
- piwaʻonoho peripheral;
- neuropathy diabetic;
- ka ulu ʻana o ka iwi (trauma, ʻoki, ulia venous o nā haʻahaʻa haʻahaʻa, a me nā mea a pau);
- nā hopena o ke ʻano maʻi.
Eia kekahi, me kēia ʻano dosage, erastrive gastritis, ʻehaʻeha nā maʻi a me ka duodenum e mālama ʻia.
Nā Hoʻohui
ʻAʻole ia e hāʻawi i no ka mea hiki ke hoʻopili pono i ka mea o ka lāʻau lapaʻau, decompensated ka puʻuwai naʻau, edema i ka ʻōnaehana bronchopulmonary, oliguria, anuria a me nā kaʻina congestive i loko o ke kino.
Me ka mālama pono
I mua o ka hyperchloremia a me ka hypernatremia, i ka wā kamaliʻi.
Pehea e lawe ai i ka Actovegin 40
Pono ka hopena, nā palapala a me nā regimens lapaʻau e pili ana i nā hiʻohiʻona o ke kaʻina pili. Hoʻoholo ʻia i kēlā me kēia. Ua hoʻohālikelike ʻia intraarterially, intravenously a me intramuscularly.
I ka mālamaʻana i nā hōʻiliʻili o ka metabolic a me nā vascular o ka lolo, i nā hoʻomaka mua o ka mālama ʻana, he 10-20 ml o iv a iv e ʻeha nei i kēlā me kēia lā. A laila, e like me ka hoʻoponopono ʻia o ka mālama ʻana, 5 ml iv a i ʻole IM me ka infusion lohi.
Ma ka wānana ischemic i ka wā ākea, ua hoʻokomo ʻia nā lāʻau lapaʻau.
I ka wailana ischemic i ke kahua mākia, hana ʻia nā infusions. No kēia, ua hoʻohui ʻia kahi lāʻau (10-50 ml) i ka 200-300 ml o ka hoʻohui isotonic (5% glucose a iʻole ka hopena o ka sodium chloride). Ma hope o kēia, ua hoʻololi ke kaola o ka lapaʻau e lawe i kahi papa papa o ka lāʻau lapaʻau.
No ka mālamaʻana i nā kūlana i hopena mai i nā maʻi vascular o ka lolo, ua kuhikuhi ʻia kēia lāʻau lapaʻau iv a iv (20-30 ml o ka lāʻau lapaʻau me ka 200 ml o kahi hoʻohui isotonic).
E hoʻopau i nā hōʻailona o ka maʻi polyneuropathy maʻi, ua hōʻike ʻia ka 50 ml o ka iv. A laila huli ke hopena therapeutic i ka hoʻohana ʻana o Actovegin i nā papa.
Me ka hoʻokele / m, a hiki i ka 5 ml ke hoʻohana ʻia. E hele mālie.
Lawe i ka lāʻau lapaʻau no ka maʻi maʻi maʻi
Hōʻike i nā lāʻau lapaʻau e hāpai i ka hana maʻamau o ka metabolism. No laila, he kauoha i ka paʻakikī o ka mālama ʻana i ka maʻi maʻi.
Pono ʻia ka lāʻau lapaʻau i ka paʻakikī o ka mālama ʻana i ka maʻi maʻi.
Nā hopena hopena
Ua holomua. I nā hanana maʻamau, hiki i nā hopena ʻaoʻao.
Mai ka ʻōnaehana musculoskeletal
ʻO Myalgia (kahi liʻiliʻi).
Mai ka pā kūlohelohe
Allergic reaksi ma ke ʻano o nā hōʻike lapaʻau o ka maʻi o ka lāʻau a i ʻole ka hoʻohālikelike anaphylactic.
Ma ka ʻāpana o ka ʻili
Ka palu ʻana, polū, a ʻulaʻula paha.
Allergies
ʻO ka hele ʻana o kahi predisposition e hōʻike i ka hōʻike maʻi alaka.
ʻO kahi hopena o ka lāʻau lapaʻau hiki ke lilo i alerio.
Nā ʻōlelo kikoʻī
Ma muli o ka hopena o ka hopena anaphylactic i ka wā hoʻohana mua, pono e hoʻokau ʻia kahi hōʻike hypersensitivity no kēia lāʻau lapaʻau ma mua o ka hoʻokele ʻana.
I nā ʻāpana holoʻokoʻa, hiki i ka lāʻau ke ʻokoʻa nā ʻoniʻoni ʻokoʻa. Akā ʻaʻole pili kēia i ka ʻae o ka lāʻau lapaʻau a me kāna hana.
ʻAʻole kūʻai pono nā ampoules. Pono lākou e hoʻohana koke.
Hoʻolaha ka waipuna
Inā ʻaʻole e pau ka inu waiʻona i kāna mau lāʻau lapaʻau.
Hoʻopilikia i ka hiki ke mālama i nā mīkini
ʻAʻohe ʻikepili i ʻole.
Inā ʻaʻole e pau ka inu waiʻona i kāna mau lāʻau lapaʻau.
Hoʻohana i ka wā hāpai a me ka lactation
ʻAʻole i mālama ʻia kahi hopena maikaʻi ʻole i ke ʻano o ka makuahine a i ka wā fetus.
Koho Actovegin 40 keiki
Hoʻonohonohoʻia i nā pēpē me nā hōʻailona o ka hypoxia. Eia kekahi, ua kauoha ʻia ka lāʻau lapaʻau no nā keiki me ka hānau ʻana a loaʻa nā hōʻeha lolo.
Hoʻohana i ka wā kahiko
Hoʻohana ʻia ia i ka mālama ʻana a me ka pale ʻana i nā pilikia o ka hypoxic a me ischemic o nā hui a me nā ʻili i nā mea maʻi pili ola.
Ke keu
ʻAʻohe hihia o ka overdose o Actovegin.
Hoʻohana ʻia ia i ka mālama ʻana a me ka pale ʻana i nā pilikia o ka hypoxic a me ischemic o nā hui a me nā ʻili i nā mea maʻi pili ola.
Aia kahi loli nui o ka hopena o nā hopena ʻaoʻao.
Hoʻopili pū me nā lāʻau ʻē aʻe
ʻAʻole i ʻike ʻia nā hopena pōʻino mai nā lōlapa.
He kūpono ia i nā lāʻau lapaʻau i hoʻohana ʻia i ka paʻakikī o ka lāʻau ischemic stroke (no ka laʻana, me Mildronate).
Eia kekahi, ua hoʻohana nui ʻia i nā lāʻau hui me nā lāʻau i hoʻohana ʻia e hoʻopau ai i ka maʻi venous a me ka plenta plenta, ma ka mālama ʻana i ka trombosis (no ka laʻana me Curantyl).
ʻO nā hui e koi ana i ka mālama
ʻO ka hui pū me nā mea paʻa o ACE (Enalapril, Lisinopril, Captopril, etc.), a me ka hoʻomākaukau ʻana no ka paʻakai, e pono ai ka makaʻala.
Nā kuʻina
Nā kaila Actovegin:
- Vero-Trimetazidine;
- Curantyl-25;
- Cortexin;
- Cerebrolysin, etc.
ʻO Curantil-25 kahi mea hoʻohālikelike o Actovegin.
Waihue huaʻōlelo waiho nā huaʻōlelo
Ma ke kumu.
Hiki iaʻu ke kūʻai me ke kī ʻole
Ua mākaukau nā lāʻau lapaʻau pūnaewele he nui no ke kūʻai aku me ʻole.
Kaukuana Actovegin 40
Aia ke kumukūʻai kumukūʻai i ka nui o nā ampoule a me kā lākou helu ma ka pākaukau. No laila, no ka laʻana, ma Rūsia, ke kumukūʻai o Actovegin (injection no 40 mg / ml ampoules o 5 ml 5 mau pcs.) Nā puke mai 580 a 700 rubles.
Ma Ukraine, kahi kumukūʻai like like me 310-370 UAH.
Kuhi ke kumukūʻai o ka lāʻau i ka nui o nā ampoule a me kā lākou helu ma ka pā.
Ke waiho nei i nā kūlana no ka lāʻau lapaʻau
Ma kahi wahi i pale ʻia mai ka wela ʻana ma ka mahana a hiki i 25 ° C. Hūnā mai nā keiki.
ʻO ka lā kau
3 mau makahiki mai ka lā i hana ai.
Mea hana
Nycomed Austria GmbH, Austria.
Packer / hoʻopuka o ka kaohi o nā mana: Takeda Pharmaceuticals LLC (Russia).
Hōʻikeʻike o nā kauka a me nā mea maʻi ma ka Actovegin 40
ʻOkoʻa nā manaʻo o nā kauka a me nā mea maʻi e pili ana i ka hoʻohana ʻana, ka maikaʻi a me ka palekana.
Vasilieva E.V., neurologist, Krasnodar
ʻO ka Actovegin ʻaʻole like me nā hopena ʻaoʻao a ʻike maikaʻi ʻia. Hiki ke hoʻohana ʻia i ka monotherapy a ma nā hoʻoponopono hoʻoponopono lāʻau paʻakikī. Koho ʻia no nā kulekele o ka ʻōnaehana vascular a me ka maikaʻiʻole o ka metabolic. Hoʻomaopopo wau i ka hapa nui o kaʻu mau maʻi.
Marina, 24 mau makahiki, Kursk
Hāʻawi lākou i nā injections a me nā ʻōpū i ka wā hapai e hoʻonā i ka kahe koko i loko o ka plasenta. ʻAʻohe hopena hopena. Ma hope o ka mālama ʻana, ua hoʻi ka kahe koko i ke ʻano maʻamau, a ua nalo ka luhi a me ka ʻilihune me ka pilikia. Kūleʻa wau i nā wahine hāpai a pau.
Nefedov I.B., 47 makahiki, Oryol
ʻOiai ka pāpā ʻana i kēia lāʻau lapaʻau e ka FDA (US Department of Health and Human Services), ke hoʻohana nui ʻia nei i Rūsia a me nā ʻāina CIS. Antigen haole. ʻAʻole wau e hilinaʻi i nā lāʻau lapaʻau, nā ʻōlelo aʻoaʻo e hōʻike ai he hiki ʻole ke loiloi i kāna mau pharmacokinetic.
Afanasyev P.F. ʻO ke kauka ultrasound, St. Petersburg
ʻO ka lāʻau antihypoxic maikaʻi me ka mālamaʻana i ka hopena therapeutic no 3-6 mau mahina. Hoʻohana nui ʻia kēia mea hana i loko o kā mākou hale waihona i ka Institute Institute. ʻO Ankylosing spondylitis no ka hoʻopau ʻana o nā hōʻailona o ka maʻi cerebrovascular a me ka discirculatory encephalopathy, nā hopena o ka hōʻeha a me ka hōʻeha o ka lolo traumatic. Kōkua i ka hoʻopau ʻana i nā hōʻeha, ka migraines, nā manaʻo o nā hopohopo, hoʻomaikaʻi i ka hana noʻonoʻo, a me nā mea ʻē aʻe.
